Summary
The Maharashtra FDA is targeting overpriced drugs, planning to approach the NPPA and enforce stricter audits on manufacturing units while ensuring hospitals allow patients to purchase medicines from any pharmacy.
Maharashtra FDA Trains Focus on Overpriced Drugs, Plans NPPA Approach
HyperFast News
Government
31 July 2026 at 5:27 am
Maharashtra FDA Trains Focus on Overpriced Drugs, Plans NPPA Approach
HyperFast News
Related & trending news
Maharashtra FDA Bans Junk Food Sales in and Around Schools, Warns of Strict Action
30 Jul 2026, 11:24 am · Education
Maharashtra FDA Seizes Rs 2.45 Crore Worth of Aciloc Drugs, Orders Market Recall Over Deceptive Labeling
12 Jul 2026, 1:02 pm · General
Maharashtra FDA Bars Sale of Two Cadila Drugs Over Branding Concerns, Seizes Stock
11 Jul 2026, 8:02 pm · Health
India takes action against 90% of inspected high-risk pharmaceutical facilities
30 Jul 2026, 9:36 pm · Regulation
Transport Minister Sarnaik: Aggregator Firms Must Register by September 1
31 Jul 2026, 9:26 am · Government
Bombay High Court Ordered Canteen Inspections, FDA Responds by Moving to Shut Down Court's Own Canteen
31 Jul 2026, 3:37 am · Government
